Logo image of FLGC

FLORA GROWTH CORP (FLGC) Stock Fundamental Analysis

NASDAQ:FLGC - Nasdaq - CA3397642016 - Common Stock - Currency: USD

0.631  -0.01 (-1.31%)

After market: 0.6436 +0.01 (+2%)

Fundamental Rating

1

Overall FLGC gets a fundamental rating of 1 out of 10. We evaluated FLGC against 35 industry peers in the Personal Care Products industry. FLGC may be in some trouble as it scores bad on both profitability and health. FLGC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

FLGC had negative earnings in the past year.
In the past year FLGC has reported a negative cash flow from operations.
In the past 5 years FLGC always reported negative net income.
In the past 5 years FLGC always reported negative operating cash flow.
FLGC Yearly Net Income VS EBIT VS OCF VS FCFFLGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

FLGC has a worse Return On Assets (-59.35%) than 82.86% of its industry peers.
FLGC's Return On Equity of -279.34% is on the low side compared to the rest of the industry. FLGC is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
ROA -59.35%
ROE -279.34%
ROIC N/A
ROA(3y)-122.26%
ROA(5y)-92.9%
ROE(3y)-445.2%
ROE(5y)-289.95%
ROIC(3y)N/A
ROIC(5y)N/A
FLGC Yearly ROA, ROE, ROICFLGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

1.3 Margins

Looking at the Gross Margin, with a value of 25.41%, FLGC is doing worse than 80.00% of the companies in the same industry.
In the last couple of years the Gross Margin of FLGC has declined.
FLGC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.89%
GM growth 5YN/A
FLGC Yearly Profit, Operating, Gross MarginsFLGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

2

2. Health

2.1 Basic Checks

FLGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
FLGC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, FLGC has more shares outstanding
FLGC has a better debt/assets ratio than last year.
FLGC Yearly Shares OutstandingFLGC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M
FLGC Yearly Total Debt VS Total AssetsFLGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

FLGC has an Altman-Z score of -8.79. This is a bad value and indicates that FLGC is not financially healthy and even has some risk of bankruptcy.
FLGC has a worse Altman-Z score (-8.79) than 94.29% of its industry peers.
FLGC has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
FLGC's Debt to Equity ratio of 0.43 is in line compared to the rest of the industry. FLGC outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z -8.79
ROIC/WACCN/A
WACC9.01%
FLGC Yearly LT Debt VS Equity VS FCFFLGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.05 indicates that FLGC should not have too much problems paying its short term obligations.
FLGC has a worse Current ratio (1.05) than 71.43% of its industry peers.
FLGC has a Quick Ratio of 1.05. This is a bad value and indicates that FLGC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.67, FLGC is doing worse than 68.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.67
FLGC Yearly Current Assets VS Current LiabilitesFLGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.23% over the past year.
FLGC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -28.78%.
The Revenue has been growing by 87.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)87.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
Revenue 1Y (TTM)-28.78%
Revenue growth 3Y87.83%
Revenue growth 5YN/A
Sales Q2Q%-34.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y81.21%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FLGC Yearly Revenue VS EstimatesFLGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 20M 40M 60M
FLGC Yearly EPS VS EstimatesFLGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -2 -4 -6 -8 -10

0

4. Valuation

4.1 Price/Earnings Ratio

FLGC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FLGC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FLGC Price Earnings VS Forward Price EarningsFLGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FLGC Per share dataFLGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FLGC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FLORA GROWTH CORP

NASDAQ:FLGC (7/17/2025, 8:24:43 PM)

After market: 0.6436 +0.01 (+2%)

0.631

-0.01 (-1.31%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-10 2025-08-10
Inst Owners3.96%
Inst Owner Change0%
Ins Owners12.7%
Ins Owner Change0%
Market Cap14.24M
Analysts82.5
Price Target2.81 (345.32%)
Short Float %1.17%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-346.11%
Min EPS beat(2)-426.8%
Max EPS beat(2)-265.42%
EPS beat(4)0
Avg EPS beat(4)-308.58%
Min EPS beat(4)-426.8%
Max EPS beat(4)-206.37%
EPS beat(8)1
Avg EPS beat(8)-455.41%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.3%
Min Revenue beat(2)-25.05%
Max Revenue beat(2)-3.55%
Revenue beat(4)0
Avg Revenue beat(4)-20.38%
Min Revenue beat(4)-27.06%
Max Revenue beat(4)-3.55%
Revenue beat(8)2
Avg Revenue beat(8)-12%
Revenue beat(12)2
Avg Revenue beat(12)-10.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-31.25%
EPS NQ rev (1m)-400%
EPS NQ rev (3m)-400%
EPS NY rev (1m)-400%
EPS NY rev (3m)-400%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B 2.99
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.96
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS2.36
BVpS0.21
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -59.35%
ROE -279.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.41%
FCFM N/A
ROA(3y)-122.26%
ROA(5y)-92.9%
ROE(3y)-445.2%
ROE(5y)-289.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.89%
GM growth 5YN/A
F-Score3
Asset Turnover2.38
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.99%
Cap/Sales 0.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.67
Altman-Z -8.79
F-Score3
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)24.35%
Cap/Depr(5y)215.63%
Cap/Sales(3y)1.3%
Cap/Sales(5y)51.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
EPS Next Y81.21%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.78%
Revenue growth 3Y87.83%
Revenue growth 5YN/A
Sales Q2Q%-34.63%
Revenue Next Year-11.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year114.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y53.14%
OCF growth 3YN/A
OCF growth 5YN/A